195 related articles for article (PubMed ID: 34448087)
21. Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.
Ballen K; Woo Ahn K; Chen M; Abdel-Azim H; Ahmed I; Aljurf M; Antin J; Bhatt AS; Boeckh M; Chen G; Dandoy C; George B; Laughlin MJ; Lazarus HM; MacMillan ML; Margolis DA; Marks DI; Norkin M; Rosenthal J; Saad A; Savani B; Schouten HC; Storek J; Szabolcs P; Ustun C; Verneris MR; Waller EK; Weisdorf DJ; Williams KM; Wingard JR; Wirk B; Wolfs T; Young JH; Auletta J; Komanduri KV; Lindemans C; Riches ML
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1636-1645. PubMed ID: 27343716
[TBL] [Abstract][Full Text] [Related]
22. Outcome of unrelated umbilical cord blood transplantation in 88 patients with primary immunodeficiency in Japan.
Morio T; Atsuta Y; Tomizawa D; Nagamura-Inoue T; Kato K; Ariga T; Kawa K; Koike K; Tauchi H; Kajiwara M; Hara T; Kato S;
Br J Haematol; 2011 Aug; 154(3):363-72. PubMed ID: 21569009
[TBL] [Abstract][Full Text] [Related]
23. Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism.
Eapen M; Ahn KW; Orchard PJ; Cowan MJ; Davies SM; Fasth A; Hassebroek A; Ayas M; Bonfim C; O'Brien TA; Gross TG; Horwitz M; Horwitz E; Kapoor N; Kurtzberg J; Majhail N; Ringden O; Szabolcs P; Veys P; Baker KS
Biol Blood Marrow Transplant; 2012 Sep; 18(9):1438-45. PubMed ID: 22430083
[TBL] [Abstract][Full Text] [Related]
24. Umbilical Cord Blood Transplantation after Graft Failure from a Previous Hematopoietic Stem Cell Transplantation.
Volt F; Ruggeri A; Scigliuolo GM; de Latour RP; Bierings M; Al-Seraihy A; Bittencourt H; Labussière-Wallet H; Rocha V; Kenzey C; Cappelli B; Rafii H; Gluckman E; Guerino-Cunha RL
Transplant Cell Ther; 2022 Jan; 28(1):46.e1-46.e7. PubMed ID: 34757218
[TBL] [Abstract][Full Text] [Related]
25. Outcome of Non-hematological Autoimmunity After Hematopoietic Cell Transplantation in Children with Primary Immunodeficiency.
Lum SH; Elfeky R; Achini FR; Margarit-Soler A; Cinicola B; Perez-Heras I; Nademi Z; Flood T; Cheetham T; Worth A; Qasim W; Amin R; Rao K; Chiesa R; Bredius RGM; Amrolia P; Abinun M; Hambleton S; Veys P; Gennery AR; Lankester A; Slatter M
J Clin Immunol; 2021 Jan; 41(1):171-184. PubMed ID: 33141919
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry.
Mitchell R; Nivison-Smith I; Anazodo A; Tiedemann K; Shaw P; Teague L; Fraser C; Carter T; Tapp H; Alvaro F; O'Brien TA
Biol Blood Marrow Transplant; 2013 Mar; 19(3):338-43. PubMed ID: 23228588
[TBL] [Abstract][Full Text] [Related]
27. Graft Versus Host Disease Following HLA-Matched Sibling Donor Compared with Matched Related Donor for Hematopoietic Stem Cell Transplantation for the Treatment of Severe Combined Immunodeficiency Disease.
Al-Saud B; Al-Saleem A; Al Rasheed B; Al-Ghonaium A; Al-Ahmari A; Al-Mousa H; Al-Seraihy A; Arnaout R; Al-Jefri A; Elshorbagi S; Elsayed N; Al-Dhekri H; Ayas M; Al-Muhsen S
J Clin Immunol; 2019 May; 39(4):414-420. PubMed ID: 31041574
[TBL] [Abstract][Full Text] [Related]
28. Hematopoietic Cell Transplantation for Chronic Granulomatous Disease in Japan.
Yanagimachi M; Kato K; Iguchi A; Sasaki K; Kiyotani C; Koh K; Koike T; Sano H; Shigemura T; Muramatsu H; Okada K; Inoue M; Tabuchi K; Nishimura T; Mizukami T; Nunoi H; Imai K; Kobayashi M; Morio T
Front Immunol; 2020; 11():1617. PubMed ID: 32849547
[TBL] [Abstract][Full Text] [Related]
29. Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources.
Ballen KK; Joffe S; Brazauskas R; Wang Z; Aljurf MD; Akpek G; Dandoy C; Frangoul HA; Freytes CO; Khera N; Lazarus HM; LeMaistre CF; Mehta P; Parsons SK; Szwajcer D; Ustun C; Wood WA; Majhail NS
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1819-27. PubMed ID: 25064747
[TBL] [Abstract][Full Text] [Related]
30. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
[TBL] [Abstract][Full Text] [Related]
31. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.
Eapen M; Rocha V; Sanz G; Scaradavou A; Zhang MJ; Arcese W; Sirvent A; Champlin RE; Chao N; Gee AP; Isola L; Laughlin MJ; Marks DI; Nabhan S; Ruggeri A; Soiffer R; Horowitz MM; Gluckman E; Wagner JE; ; ;
Lancet Oncol; 2010 Jul; 11(7):653-60. PubMed ID: 20558104
[TBL] [Abstract][Full Text] [Related]
32. Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: an analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Murata M; Nakasone H; Kanda J; Nakane T; Furukawa T; Fukuda T; Mori T; Taniguchi S; Eto T; Ohashi K; Hino M; Inoue M; Ogawa H; Atsuta Y; Nagamura-Inoue T; Yabe H; Morishima Y; Sakamaki H; Suzuki R
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1183-9. PubMed ID: 23676716
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
[TBL] [Abstract][Full Text] [Related]
34. Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC.
Cuvelier GDE; Logan BR; Prockop SE; Buckley RH; Kuo CY; Griffith LM; Liu X; Yip A; Hershfield MS; Ayoub PG; Moore TB; Dorsey MJ; O'Reilly RJ; Kapoor N; Pai SY; Kapadia M; Ebens CL; Forbes Satter LR; Burroughs LM; Petrovic A; Chellapandian D; Heimall J; Shyr DC; Rayes A; Bednarski JJ; Chandra S; Chandrakasan S; Gillio AP; Madden L; Quigg TC; Caywood EH; Dávila Saldaña BJ; DeSantes K; Eissa H; Goldman FD; Rozmus J; Shah AJ; Vander Lugt MT; Thakar MS; Parrott RE; Martinez C; Leiding JW; Torgerson TR; Pulsipher MA; Notarangelo LD; Cowan MJ; Dvorak CC; Haddad E; Puck JM; Kohn DB
Blood; 2022 Aug; 140(7):685-705. PubMed ID: 35671392
[TBL] [Abstract][Full Text] [Related]
35. Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source.
Damodar S; Shanley R; MacMillan M; Ustun C; Weisdorf D
Biol Blood Marrow Transplant; 2017 May; 23(5):795-804. PubMed ID: 28232088
[TBL] [Abstract][Full Text] [Related]
36. Similar outcomes of allogeneic hematopoietic cell transplantation from unrelated donor and umbilical cord blood vs. sibling donor for pediatric acute myeloid leukemia: Multicenter experience in China.
Tang X; Chen J; Fang J; Sun X; Qin MQ; Li J; Zhu Y; Luan Z
Pediatr Transplant; 2015 Jun; 19(4):413-21. PubMed ID: 25903451
[TBL] [Abstract][Full Text] [Related]
37. Transfusion burden following reduced intensity allogeneic hematopoietic cell transplantation: Impact of donor type.
Subramanian S; Cohn C; DeFor T; Welbig J; Brunstein C; El Jurdi N; Weisdorf D
Transfusion; 2021 Jul; 61(7):2064-2074. PubMed ID: 33899243
[TBL] [Abstract][Full Text] [Related]
38. Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: A study on behalf of the Donor/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular Therapy.
Konuma T; Harada K; Shinohara A; Uchida N; Shingai N; Ito A; Ozawa Y; Tanaka M; Sawa M; Onizuka M; Katayama Y; Hiramoto N; Nakano N; Kimura T; Kanda Y; Fukuda T; Atsuta Y; Nakasone H; Kanda J
Am J Hematol; 2024 Feb; 99(2):263-273. PubMed ID: 38164974
[TBL] [Abstract][Full Text] [Related]
39. Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study.
González-Vicent M; Molina B; Andión M; Sevilla J; Ramirez M; Pérez A; Díaz MA
Eur J Haematol; 2011 Jul; 87(1):46-53. PubMed ID: 21692851
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis.
Ustun C; Giannotti F; Zhang MJ; Wang HL; Brunstein C; Labopin M; Rocha V; de Lima M; Baron F; Sandmaier BM; Eapen M; Gluckman E; Nagler A; Weisdorf DJ; Ruggeri A
Leukemia; 2017 Jun; 31(6):1408-1414. PubMed ID: 28119528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]